ITX-4520
Product Specifications
CAS Number
1392116-37-8
Target
Others|||HCV Protease
Related Pathways
Proteases/Proteasome|||Others|||Microbiology/Virology
Bioactivity
ITX-4520 novel highly potent, orally bioavailable inhibitor of hepatitis C virus (HCV) entry.
Smiles
C(CCSC1=CC(F)=CC(F)=C1)N2C=3C(C4=C2CCCC4)=CC(=CC3)C5=NC(C)=NO5
Molecular Formula
C24H23F2N3OS
Molecular Weight
439.52
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1029353-01 0.02 mg (E-Coli)
Recombinant Staphylococcus aureus 2,3,4,5-tetrahydropyridine-2,6-dicarboxylate N-acetyltransferase (dapH)
Ask
View Details 
MBS1029353-02 0.1 mg (E-Coli)
Recombinant Staphylococcus aureus 2,3,4,5-tetrahydropyridine-2,6-dicarboxylate N-acetyltransferase (dapH)
Ask
View Details MBS1029353-03 0.02 mg (Yeast)
Recombinant Staphylococcus aureus 2,3,4,5-tetrahydropyridine-2,6-dicarboxylate N-acetyltransferase (dapH)
Ask
View Details MBS1029353-04 0.1 mg (Yeast)
Recombinant Staphylococcus aureus 2,3,4,5-tetrahydropyridine-2,6-dicarboxylate N-acetyltransferase (dapH)
Ask
View Details MBS1029353-05 0.02 mg (Baculovirus)
Recombinant Staphylococcus aureus 2,3,4,5-tetrahydropyridine-2,6-dicarboxylate N-acetyltransferase (dapH)
Ask
View Details MBS1029353-06 0.02 mg (Mammalian-Cell)
Recombinant Staphylococcus aureus 2,3,4,5-tetrahydropyridine-2,6-dicarboxylate N-acetyltransferase (dapH)
Ask
View Details